ReMed ApS: Financial statements 2023
CVR: 39182408
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ReMed ApS (CVR 39182408) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -31,863 and a net result of DKK -195,481 compared with DKK -197,969 the year before. Equity in the 2023 report amounted to DKK -1,034,941.
- Gross Profit
- DKK -31,863
- Profit/Loss
- DKK -195,481
- Equity
- DKK -1,034,941
- Total Assets
- DKK 5,508,680
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -32 t. | -195 t. | -1 mio. | - |
| 2022 | - | -40 t. | -198 t. | -839 t. | - |
| 2020 | - | -38 t. | -203 t. | -433 t. | - |
| 2019 | - | -40 t. | -183 t. | -230 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ReMed ApS has published its annual report for 2022. Gross profit came to DKK -40,370, and the net result was DKK -197,969.
About ReMed ApS
ReMed ApS is a Danish company of the type Anpartsselskab based in Rønde, founded in 2017. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The management consists of Jette Søndergaard and Jørn Aagaard. The company is owned by AAGAARD GYNÆKOLOGISK KLINIK ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -10,750 and a net result of DKK -4,608,195 compared with DKK -188,171 the year before. Equity in the 2025 report amounted to DKK -5,831,307.